130 related articles for article (PubMed ID: 3413798)
1. Hepatic ATP content and hyperammonemia induced by CCl4 in rats.
Yamamoto HA; Sugihara N
Toxicology; 1988 Sep; 51(1):111-7. PubMed ID: 3413798
[TBL] [Abstract][Full Text] [Related]
2. Blood ammonia levels and hepatic encephalopathy induced by CCl4 in rats.
Yamamoto H; Sugihara N
Toxicol Appl Pharmacol; 1987 Dec; 91(3):461-8. PubMed ID: 2962338
[TBL] [Abstract][Full Text] [Related]
3. Brain phenylalanine and tyrosine levels and hepatic encephalopathy induced by CCl4 in rats.
Yamamoto H
Toxicology; 1990 Apr; 61(3):241-7. PubMed ID: 2330597
[TBL] [Abstract][Full Text] [Related]
4. Altered hepatic energy status in chlordecone (Kepone)-potentiated CCl4 hepatotoxicity.
Kodavanti PR; Kodavanti UP; Mehendale HM
Biochem Pharmacol; 1990 Aug; 40(4):859-66. PubMed ID: 1696822
[TBL] [Abstract][Full Text] [Related]
5. Protection from chlordecone-amplified carbon tetrachloride toxicity by cyanidanol: biochemical and histological studies.
Soni MG; Mehendale HM
Toxicol Appl Pharmacol; 1991 Mar; 108(1):46-57. PubMed ID: 1706539
[TBL] [Abstract][Full Text] [Related]
6. The protective effect of HD-03 in CCl4-induced hepatic encephalopathy in rats.
Mitra SK; Venkataranganna MV; Gopumadhavan S; Anturlikar SD; Seshadri SJ; Venkatesha Udupa U
Phytother Res; 2001 Sep; 15(6):493-6. PubMed ID: 11536377
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hyperammonemia with carbamylglutamate in rats.
Grau E; Felipo V; Miñana MD; Grisolía S
Hepatology; 1992 Mar; 15(3):446-8. PubMed ID: 1544625
[TBL] [Abstract][Full Text] [Related]
8. Change of hepatic histamine content during hepatic fibrosis.
Umezu K; Yuasa S; Sudoh A
Biochem Pharmacol; 1985 Jun; 34(11):2007-11. PubMed ID: 4004917
[TBL] [Abstract][Full Text] [Related]
9. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
[TBL] [Abstract][Full Text] [Related]
10. Salicylate potentiates valproate-induced hyperammonemia in the rat.
Uetrecht JP
Pharmacology; 1987; 34(5):279-85. PubMed ID: 3112809
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice.
Gupta S; Rogers LK; Taylor SK; Smith CV
Toxicol Appl Pharmacol; 1997 Oct; 146(2):317-27. PubMed ID: 9344900
[TBL] [Abstract][Full Text] [Related]
12. Adenosine triphosphate protection of chlordecone-amplified CCl4 hepatotoxicity and lethality.
Soni MG; Mehendale HM
J Hepatol; 1994 Feb; 20(2):267-74. PubMed ID: 7516359
[TBL] [Abstract][Full Text] [Related]
13. Failure of the normal ureagenic response to amino acids in organic acid-loaded rats. Proposed mechanism for the hyperammonemia of propionic and methylmalonic acidemia.
Stewart PM; Walser M
J Clin Invest; 1980 Sep; 66(3):484-92. PubMed ID: 7400325
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cirrhotic rats with L-ornithine-L-aspartate enhances urea synthesis and lowers serum ammonia levels.
Gebhardt R; Beckers G; Gaunitz F; Haupt W; Jonitza D; Klein S; Scheja L
J Pharmacol Exp Ther; 1997 Oct; 283(1):1-6. PubMed ID: 9336301
[TBL] [Abstract][Full Text] [Related]
15. [The relationship of CPS-I, OCT and hepatic encephalopathy].
He Y; Song HL; Li GX; Xu J; Gao BX; Yu T; Tang SQ
Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):699-702. PubMed ID: 20943084
[TBL] [Abstract][Full Text] [Related]
16. Long-chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action.
Tomomura M; Tomomura A; Dewan MA; Saheki T
FEBS Lett; 1996 Dec; 399(3):310-2. PubMed ID: 8985169
[TBL] [Abstract][Full Text] [Related]
17. Ameliorative effects of rutin on hepatic encephalopathy-induced by thioacetamide or gamma irradiation.
Mansour SZ; El-Marakby SM; Moawed FSM
J Photochem Photobiol B; 2017 Jul; 172():20-27. PubMed ID: 28505498
[TBL] [Abstract][Full Text] [Related]
18. Medium-chain triglycerides supplement therapy with a low-carbohydrate formula can supply energy and enhance ammonia detoxification in the hepatocytes of patients with adult-onset type II citrullinemia.
Hayasaka K; Numakura C; Yamakawa M; Mitsui T; Watanabe H; Haga H; Yazaki M; Ohira H; Ochiai Y; Tahara T; Nakahara T; Yamashiki N; Nakayama T; Kon T; Mitsubuchi H; Yoshida H
J Inherit Metab Dis; 2018 Sep; 41(5):777-784. PubMed ID: 29651749
[TBL] [Abstract][Full Text] [Related]
19. Influence of 2,4-dinitrophenol on the susceptibility of rats to hepatotoxic injury.
Strubelt O
Toxicol Lett; 1981 Nov; 9(3):221-4. PubMed ID: 7314128
[TBL] [Abstract][Full Text] [Related]
20. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats.
Vogels BA; Maas MA; Daalhuisen J; Quack G; Chamuleau RA
Hepatology; 1997 Apr; 25(4):820-7. PubMed ID: 9096582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
